{"transactions":[{"id":727528,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T21:10:58.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":30700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company."}],"balance_after":30700,"derivative":{"exercise_price":0.98,"expiration_date":"2036-06-21","underlying":"Common Stock","underlying_shares":30700},"source":{"system":"sec-edgar","filing":"0001305178-26-000002","document":"form4-06242026_090654.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000130517826000002/form4-06242026_090654.xml","form_type":"4"}},{"id":727527,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T21:10:58.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":5100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company."}],"balance_after":13647,"source":{"system":"sec-edgar","filing":"0001305178-26-000002","document":"form4-06242026_090654.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000130517826000002/form4-06242026_090654.xml","form_type":"4"}},{"id":919257,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-05T00:15:03.000Z","date":"2026-02-03","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001193125-26-038002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000119312526038002/ownership.xml","form_type":"4"}},{"id":919256,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-05T00:15:03.000Z","date":"2026-02-04","kind":"sale","planned":false,"acquired":false,"shares":1558,"price":0.976,"value":1520.608,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Sale made by the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 3, 2022."}],"balance_after":37296,"source":{"system":"sec-edgar","filing":"0001193125-26-038002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000119312526038002/ownership.xml","form_type":"4"}},{"id":919255,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-05T00:15:03.000Z","date":"2026-02-03","kind":"exercise","planned":false,"acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":38854,"source":{"system":"sec-edgar","filing":"0001193125-26-038002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000119312526038002/ownership.xml","form_type":"4"}},{"id":941989,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-09T22:42:27.000Z","date":"2026-01-09","kind":"grant","planned":false,"acquired":true,"shares":412500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning February 9, 2026, such that this option will be fully exercisable on January 9, 2029. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer."}],"balance_after":412500,"derivative":{"exercise_price":0.7127,"expiration_date":"2036-01-09","underlying":"Common Stock","underlying_shares":412500},"source":{"system":"sec-edgar","filing":"0001193125-26-009156","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000119312526009156/ownership.xml","form_type":"4"}},{"id":946129,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T21:00:09.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":24400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option becomes fully exercisable on the first anniversary of the grant date."}],"balance_after":24400,"derivative":{"exercise_price":0.34,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":24400},"source":{"system":"sec-edgar","filing":"0001193125-26-004358","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000119312526004358/ownership.xml","form_type":"4"}},{"id":1013782,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-24T20:46:52.000Z","date":"2025-10-23","kind":"grant","planned":false,"acquired":true,"shares":25600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company."}],"balance_after":25600,"derivative":{"exercise_price":1.14,"expiration_date":"2035-10-22","underlying":"Common Stock","underlying_shares":25600},"source":{"system":"sec-edgar","filing":"0001305178-25-000004","document":"form4-10242025_081048.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000130517825000004/form4-10242025_081048.xml","form_type":"4"}},{"id":1013781,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-24T20:46:52.000Z","date":"2025-10-23","kind":"grant","planned":false,"acquired":true,"shares":4267,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company."}],"balance_after":8547,"source":{"system":"sec-edgar","filing":"0001305178-25-000004","document":"form4-10242025_081048.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000130517825000004/form4-10242025_081048.xml","form_type":"4"}},{"id":1119431,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-06T20:00:05.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":48800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 4, 2025. The shares underlying the option are scheduled to vest over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly installments."}],"balance_after":48800,"derivative":{"exercise_price":0.62,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":48800},"source":{"system":"sec-edgar","filing":"0000950170-25-083026","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000095017025083026/ownership.xml","form_type":"4"}},{"id":1284397,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-04T23:14:28.000Z","date":"2025-02-03","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":3750,"derivative":{"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0000950170-25-013884","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000095017025013884/ownership.xml","form_type":"4"}},{"id":1284396,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-04T23:14:28.000Z","date":"2025-02-04","kind":"sale","planned":false,"acquired":false,"shares":1254,"price":3.78,"value":4740.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Sale made by the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 3, 2022."}],"balance_after":31763,"source":{"system":"sec-edgar","filing":"0000950170-25-013884","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000095017025013884/ownership.xml","form_type":"4"}},{"id":1284395,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-04T23:14:28.000Z","date":"2025-02-03","kind":"exercise","planned":false,"acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,307 shares acquired on November 15, 2024 under the Company's 2015 Employee Purchase Plan."}],"balance_after":33017,"source":{"system":"sec-edgar","filing":"0000950170-25-013884","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000095017025013884/ownership.xml","form_type":"4"}},{"id":1305045,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-10T21:05:11.000Z","date":"2025-01-08","kind":"grant","planned":false,"acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning February 8, 2025, such that this option will be fully exercisable on January 8, 2029. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer."}],"balance_after":275000,"derivative":{"exercise_price":3.74,"expiration_date":"2035-01-08","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0000950170-25-004145","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000095017025004145/ownership.xml","form_type":"4"}},{"id":1470572,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-24T23:11:13.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":13044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company."}],"balance_after":13044,"derivative":{"exercise_price":0.885,"expiration_date":"2034-06-23","underlying":"Common Stock","underlying_shares":13044},"source":{"system":"sec-edgar","filing":"0001415889-24-018073","document":"form4-06242024_110610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000141588924018073/form4-06242024_110610.xml","form_type":"4"}},{"id":1470571,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-24T23:11:13.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":2174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company."}],"balance_after":4280,"source":{"system":"sec-edgar","filing":"0001415889-24-018073","document":"form4-06242024_110610.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000141588924018073/form4-06242024_110610.xml","form_type":"4"}},{"id":1494956,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-03T12:38:39.000Z","date":"2024-05-31","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.79,"value":8950.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,139 shares acquired on May 15, 2024 under the Company's 2015 Employee Purchase Plan."}],"balance_after":27960,"source":{"system":"sec-edgar","filing":"0000950170-24-067668","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000095017024067668/ownership.xml","form_type":"4"}},{"id":1656684,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-07T01:18:28.000Z","date":"2024-02-05","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":7500,"derivative":{"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001209191-24-002947","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919124002947/doc4.xml","form_type":"4"}},{"id":1656683,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2024-02-07T01:18:28.000Z","date":"2024-02-06","kind":"sale","planned":false,"acquired":false,"shares":1590,"price":1.69,"value":2687.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Sale made by the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 3, 2022."}],"balance_after":20821,"source":{"system":"sec-edgar","filing":"0001209191-24-002947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919124002947/doc4.xml","form_type":"4"}},{"id":1656682,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2024-02-07T01:18:28.000Z","date":"2024-02-05","kind":"exercise","planned":false,"acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":22411,"source":{"system":"sec-edgar","filing":"0001209191-24-002947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919124002947/doc4.xml","form_type":"4"}},{"id":1682552,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option  (right to buy)","published_at":"2024-01-10T00:33:59.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning February 5, 2024, such that this option will be fully exercisable on January 5, 2028.  This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer."}],"balance_after":150000,"derivative":{"exercise_price":1.5,"expiration_date":"2034-01-05","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-24-001299","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919124001299/doc4.xml","form_type":"4"}},{"id":1712384,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-13T21:23:33.000Z","date":"2023-10-10","kind":"grant","planned":false,"acquired":true,"shares":3487,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company."}],"balance_after":3487,"derivative":{"exercise_price":0.684,"exercise_date":"2024-10-10","expiration_date":"2033-10-10","underlying":"Common Stock","underlying_shares":3487},"source":{"system":"sec-edgar","filing":"0001209191-23-058479","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919123058479/doc4.xml","form_type":"4"}},{"id":1712383,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:23:33.000Z","date":"2023-10-10","kind":"grant","planned":false,"acquired":true,"shares":581,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Effective on October 25, 2022, the issuer effected a 20 to 1 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":2106,"source":{"system":"sec-edgar","filing":"0001209191-23-058479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919123058479/doc4.xml","form_type":"4"}},{"id":2003242,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option  (right to buy)","published_at":"2023-02-21T22:04:44.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":84023,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 16, 2023, such that this option will be fully exercisable on February 16, 2027.  This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer."}],"balance_after":84023,"derivative":{"exercise_price":2.195,"expiration_date":"2033-02-16","underlying":"Common Stock","underlying_shares":84023},"source":{"system":"sec-edgar","filing":"0001209191-23-011275","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919123011275/doc4.xml","form_type":"4"}},{"id":2030426,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-07T00:00:37.000Z","date":"2023-02-03","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":11250,"derivative":{"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001209191-23-007364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919123007364/doc4.xml","form_type":"4"}},{"id":2030425,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2023-02-07T00:00:37.000Z","date":"2023-02-06","kind":"sale","acquired":false,"shares":1566,"price":2.36,"value":3695.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Sale made by the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 3, 2022."}],"balance_after":15460,"source":{"system":"sec-edgar","filing":"0001209191-23-007364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919123007364/doc4.xml","form_type":"4"}},{"id":2030424,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2023-02-07T00:00:37.000Z","date":"2023-02-03","kind":"exercise","acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 986 shares acquired under that Company's 2015 Employee Stock Purchase Plan on November 15, 2022."}],"balance_after":17026,"source":{"system":"sec-edgar","filing":"0001209191-23-007364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919123007364/doc4.xml","form_type":"4"}},{"id":2206896,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-15T23:35:13.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company."}],"balance_after":31000,"derivative":{"exercise_price":0.2309,"exercise_date":"2022-07-15","expiration_date":"2032-07-14","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001209191-22-042311","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919122042311/doc4.xml","form_type":"4"}},{"id":2206895,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-15T23:35:13.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company."}],"balance_after":30500,"source":{"system":"sec-edgar","filing":"0001209191-22-042311","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919122042311/doc4.xml","form_type":"4"}},{"id":2223043,"issuer":{"id":116495,"kind":"organization","name":"OTONOMY, INC.","symbol":"OTIC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-23T16:31:06.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date, and (ii) the date of the Issuer's next annual meeting of stockholders occurring after the grant date, provided that the Reporting Person remains a service provider through such date."}],"balance_after":27500,"derivative":{"exercise_price":1.95,"expiration_date":"2032-06-20","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001209191-22-038883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493566/000120919122038883/doc4.xml","form_type":"4"}},{"id":2255071,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option  (right to buy)","published_at":"2022-05-26T20:32:49.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":75347,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 24, 2022, such that this option will be fully exercisable on May 24, 2026.  This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer."}],"balance_after":75347,"derivative":{"exercise_price":2.81,"expiration_date":"2032-05-24","underlying":"Common Stock","underlying_shares":75347},"source":{"system":"sec-edgar","filing":"0001209191-22-032209","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919122032209/doc4.xml","form_type":"4"}},{"id":2410009,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-07T21:56:00.000Z","date":"2022-02-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs are scheduled to vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs are scheduled to vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":15000,"derivative":{"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-007489","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919122007489/doc4.xml","form_type":"4"}},{"id":2410008,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option  (right to buy)","published_at":"2022-02-07T21:56:00.000Z","date":"2022-02-03","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 3, 2022, such that this option will be fully exercisable on February 3, 2026.  This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer."}],"balance_after":30000,"derivative":{"exercise_price":5.52,"expiration_date":"2032-02-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-22-007489","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919122007489/doc4.xml","form_type":"4"}},{"id":2433589,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2022-01-18T13:39:32.000Z","date":"2022-01-13","kind":"purchase","acquired":true,"shares":1923,"price":6.75,"value":12980.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 178 shares acquired under the Company's 2015 Employee Stock Purchase Plan on November 15, 2021."}],"balance_after":12112,"source":{"system":"sec-edgar","filing":"0001209191-22-003419","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919122003419/doc4.xml","form_type":"4"}},{"id":2497645,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Receive)","published_at":"2021-11-23T22:37:13.000Z","date":"2021-11-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vest on the one-year anniversary of the date of grant and the remaining shares subject to the option vest on an equal monthly basis over the following 24 months."}],"balance_after":30000,"derivative":{"exercise_price":0.72,"expiration_date":"2031-11-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-066559","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919121066559/doc4.xml","form_type":"4"}},{"id":2497644,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-23T22:37:13.000Z","date":"2021-11-20","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units shall vest in three equal consecutive annual installments on November 20, 2022, November 20, 2023 and November 20, 2024."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-21-066559","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919121066559/doc4.xml","form_type":"4"}},{"id":2594835,"issuer":{"id":116495,"kind":"organization","name":"OTONOMY, INC.","symbol":"OTIC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-20T18:36:21.000Z","date":"2021-08-18","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3 of the shares subject to the option shall vest upon each anniversary of the grant date, provided that the Reporting Person remains a service provider through each applicable vesting date."}],"balance_after":35000,"derivative":{"exercise_price":1.42,"expiration_date":"2031-08-18","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-21-052839","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493566/000120919121052839/doc4.xml","form_type":"4"}},{"id":2696752,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2021-05-26T01:04:09.000Z","date":"2021-05-21","kind":"grant","acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 21, 2021, such that this option will be fully exercisable on May 21, 2025.  This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer."}],"balance_after":54000,"derivative":{"exercise_price":4.45,"expiration_date":"2025-05-21","underlying":"Common Stock","underlying_shares":54000},"source":{"system":"sec-edgar","filing":"0001209191-21-035833","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919121035833/doc4.xml","form_type":"4"}},{"id":2871595,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-02-10T02:15:31.000Z","date":"2021-02-06","kind":"exercise","acquired":false,"shares":892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSU grant vests as to one-half (1/2) of the total number of units on each one year anniversary of the grant commencing on February 6, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSU grant vests as to one-half (1/2) of the total number of units on each one year anniversary of the grant commencing on February 6, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":892},"source":{"system":"sec-edgar","filing":"0001209191-21-009113","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919121009113/doc4.xml","form_type":"4"}},{"id":2871594,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2021-02-10T02:15:31.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":390,"price":7.66,"value":2987.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Sale made by the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 6, 2019."}],"balance_after":9833,"source":{"system":"sec-edgar","filing":"0001209191-21-009113","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919121009113/doc4.xml","form_type":"4"}},{"id":2871593,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2021-02-10T02:15:31.000Z","date":"2021-02-06","kind":"exercise","acquired":true,"shares":892,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 6, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 178 shares acquired under that Company's 2015 Employee Stock Purchase Plan on November 16, 2020."}],"balance_after":10223,"source":{"system":"sec-edgar","filing":"0001209191-21-009113","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919121009113/doc4.xml","form_type":"4"}},{"id":2874323,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option  (right to buy)","published_at":"2021-02-09T01:08:33.000Z","date":"2021-02-04","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 4, 2021, such that this option will be fully exercisable on February 4, 2025.  This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer."}],"balance_after":50000,"derivative":{"exercise_price":4.52,"expiration_date":"2031-02-04","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-21-008628","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919121008628/doc4.xml","form_type":"4"}},{"id":3101804,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-23T20:27:32.000Z","date":"2020-06-19","kind":"purchase","acquired":true,"shares":1850,"price":4.22,"value":7807.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents weighted average price for the shares. The shares were purchased at price ranging from $4.21 to $4.24 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":9153,"source":{"system":"sec-edgar","filing":"0001209191-20-038468","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919120038468/doc4.xml","form_type":"4"}},{"id":3131988,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-05-29T00:22:29.000Z","date":"2020-05-26","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"50% of the shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 26, 2020, such that these shares will be fully exercisable on May 26, 2024; 25% of the shares subject to this option will vest on May 26, 2021 if and only if a clinical development milestone is achieved by September 30, 2020; and the remaining 25% of the shares will vest on May 26, 2021 if and only if an additional clinical development milestone is achieved by September 30, 2020."}],"balance_after":30000,"derivative":{"exercise_price":4.06,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-20-032784","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919120032784/doc4.xml","form_type":"4"}},{"id":3284337,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-02-08T00:30:26.000Z","date":"2020-02-06","kind":"exercise","acquired":false,"shares":893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSU grant vests as to one-half (1/2) of the total number of units on each one year anniversary of the grant commencing on February 6, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSU grant vests as to one-half (1/2) of the total number of units on each one year anniversary of the grant commencing on February 6, 2020."}],"balance_after":893,"derivative":{"underlying":"Common Stock","underlying_shares":893},"source":{"system":"sec-edgar","filing":"0001209191-20-007710","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919120007710/doc4.xml","form_type":"4"}},{"id":3284336,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option  (right to buy)","published_at":"2020-02-08T00:30:26.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":23359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 5, 2020, such that this option will be fully exercisable on February 5, 2024.  This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer."}],"balance_after":23359,"derivative":{"exercise_price":4.39,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":23359},"source":{"system":"sec-edgar","filing":"0001209191-20-007710","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919120007710/doc4.xml","form_type":"4"}},{"id":3284335,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2020-02-08T00:30:26.000Z","date":"2020-02-07","kind":"sale","acquired":false,"shares":375,"price":4.03,"value":1511.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Sale made by the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 6, 2019."}],"balance_after":7125,"source":{"system":"sec-edgar","filing":"0001209191-20-007710","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919120007710/doc4.xml","form_type":"4"}},{"id":3284334,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2020-02-08T00:30:26.000Z","date":"2020-02-06","kind":"exercise","acquired":true,"shares":893,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 6, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 718 shares acquired under that Company's 2015 Employee Stock Purchase Plan on November 16, 2019."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001209191-20-007710","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919120007710/doc4.xml","form_type":"4"}},{"id":3667887,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-02-09T00:16:48.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs are scheduled to vest in two equal annual installments beginning on February 6, 2020, such that the RSUs will fully vest on February 6, 2021. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs are scheduled to vest in two equal annual installments beginning on February 6, 2020, such that the RSUs will fully vest on February 6, 2021. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":25000,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-008757","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919119008757/doc4.xml","form_type":"4"}},{"id":3667886,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option  (right to buy)","published_at":"2019-02-09T00:16:48.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 6, 2019, such that this option will be fully exercisable on February 6, 2023.  This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer."}],"balance_after":50000,"derivative":{"exercise_price":0.5172,"expiration_date":"2029-02-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-19-008757","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919119008757/doc4.xml","form_type":"4"}},{"id":3809775,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-09-21T20:38:58.000Z","date":"2018-09-20","kind":"purchase","acquired":true,"shares":38000,"price":0.8352,"value":31737.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average price for the shares. The shares were purchased at price ranging from $0.8229 to $0.8480 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":90000,"source":{"system":"sec-edgar","filing":"0001209191-18-051897","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919118051897/doc4.xml","form_type":"4"}},{"id":3809774,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-09-21T20:38:58.000Z","date":"2018-09-19","kind":"purchase","acquired":true,"shares":26000,"price":0.8122,"value":21117.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents weighted average price for the shares. The shares were purchased at price ranging from $0.7989 to $0.8184 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":52000,"source":{"system":"sec-edgar","filing":"0001209191-18-051897","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919118051897/doc4.xml","form_type":"4"}},{"id":3812543,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-09-18T22:12:24.000Z","date":"2018-09-14","kind":"purchase","acquired":true,"shares":26000,"price":0.7329,"value":19055.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents weighted average price for the shares. The shares were purchased at price ranging from $0.729 to $0.736 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":26000,"source":{"system":"sec-edgar","filing":"0001209191-18-051547","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919118051547/doc4.xml","form_type":"4"}},{"id":3856716,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":35630,"kind":"person","name":"Broadfoot Jill Marie","position":1,"cik":"0001305178","reported_name":"Broadfoot Jill Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-08-01T20:56:51.000Z","date":"2018-07-30","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the shares subject to this option shall vest and become exercisable on July 30, 2018, and the remainder shall thereafter vest and become exercisable in 36 equal monthly installments, such that this option will be fully exercisable on July 30, 2022. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":200000,"derivative":{"exercise_price":0.8151,"expiration_date":"2028-07-30","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-18-044758","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305178/000120919118044758/doc4.xml","form_type":"4"}}]}